1. Introduction {#sec1}
===============

Coronary artery disease (CAD) caused by atherosclerosis is a leading cause of adult death in developed countries \[[@B1]\]. In South Korea, westernization of eating habits and aging of the population are today associated with high CAD-associated morbidity and mortality. Atherosclerosis is a multifactorial disease involving several cardiovascular risk factors including dyslipidemia, high blood pressure, a high blood glucose level, and smoking. Recent studies have shown that atherosclerosis is not a passive injury caused by deposition of serum lipids and other substances on vascular walls but rather is an active inflammatory process \[[@B2]\]. Leukocytes are activated during inflammation, triggering the development of atherosclerosis and greatly increasing the risk of thrombus formation \[[@B3]\].

The neutrophil-lymphocyte ratio (NLR) (the neutrophil count divided by the lymphocyte count) is easily derived and serves as an indicator of systemic inflammation \[[@B4], [@B5]\]. The NLR is prognostic of acute coronary syndrome and is considered a much more reliable predictor than is any other predictor based on leukocyte data \[[@B6], [@B7]\]. The NLR is a marker of inflammation and is predictive of death, myocardial infarction, and coronary artery disease \[[@B6], [@B8], [@B9]\]. A high NLR is prognostic of atherosclerotic progression \[[@B10]\]. Furthermore, many epidemiological studies have shown that chronic low-grade inflammation, as indicated by the NLR, plays roles in diabetes, hypertension, metabolic syndrome, obesity, dyslipidemia, and endothelial dysfunction \[[@B11], [@B12]\].

Coronary multidetector computed tomography (MDCT) is a relatively novel method used to diagnose coronary artery disease. The coronary artery calcium score (CACS) reflects the extent of calcification of the coronary arteries. The CACS was calculated by the method of Agatston et al., yielding a total CACS that is the sum of the CACSs of each artery \[[@B13]\]. A higher CACS indicates a higher risk of CVD \[[@B14]\]. The CACS is proportional to the extent of atherosclerotic plaque and can predict coronary artery stenosis, another independent predictor of ischemic heart disease \[[@B15], [@B16]\]. Calculation of CACSs would assist in reducing the incidence of ischemic heart disease, allowing an early diagnosis of coronary artery atherosclerosis.

Today, the Framingham risk score, which considers various risk factors (age, sex, high blood pressure, the presence of diabetes, dyslipidemia, and smoking), is widely used to evaluate the risk of CVD. However, approximately half of all patients with CVD have either none or one of these risk factors \[[@B17], [@B18]\]. As inflammation is associated with atherosclerosis development and progression, we hypothesized that the NLR, considered in combination with other risk factors, aids in the prediction of CVD. Thus, we explored whether the NLR was associated with atherosclerosis measured by the CACS in healthy Korean subjects.

2. Materials and Methods {#sec2}
========================

2.1. Study Population {#sec2.1}
---------------------

The study subjects were 1,009 adults who underwent complete physical examinations and MDCT in the Health Promotion Center of a general hospital located in Gyeonggi-do, Korea. Of these subjects, those who had cancer, angina pectoris, acute myocardial infarction, and cerebral or peripheral vascular disease were excluded, as were those diagnosed with hypertension or diabetes or who were taking medications to treat these conditions. We performed more than two checkups on all subjects and excluded those who, on any checkup, had a systolic blood pressure \>140 mmHg, a diastolic pressure \>90 mmHg, and a blood fasting blood sugar level \>126 mL/dL. Also, subjects with white blood cell (WBC) counts \>10,000/*μ*L were excluded, because they may have had acute infectious disease. Finally, 599 subjects participated in the study.

2.2. Methods {#sec2.2}
------------

### 2.2.1. Basic Survey and Physical Examination {#sec2.2.1}

Before examination, we recorded any history of high blood pressure, diabetes, angina pectoris, or myocardial infarction. Additionally, we noted the medications used, smoking history, drinking history, and exercise habits. Weight and height were estimated to the nearest 100 g and 1 cm, respectively. BMI was calculated as weight (kg)/height^2^ (m^2^). Waist circumference (WC) was measured under the ribs (at the upper midpoint of the crista iliaca) to the nearest 1 cm, with each subject erect, feet 30 cm apart, and exhaling comfortably. Blood pressure was measured automatically after each subject had been seated for 20 min.

### 2.2.2. Biochemical Tests {#sec2.2.2}

Blood was drawn from the brachial vein the morning after an overnight fast. We measured WBC, neutrophil, and lymphocyte counts and the blood levels of fasting glucose (FBG), total cholesterol, high-density lipoprotein cholesterol, triglycerides (TG), aspartate transaminase, alanine transaminase (ALT), gamma-glutamyl transpeptidase (a-GTP), creatinine, high-sensitivity C-reactive protein, uric acid, calcium, phosphate, and albumin.

### 2.2.3. CACS {#sec2.2.3}

CACSs were calculated from the heart CT scans obtained using the aid of a 64-slice MDCT scanner (Sensation 64; Siemens, Erlangen, Germany). Scans were obtained after at least 6 h of fasting, with caffeine intake prohibited. If the heart rate of a subject who was not on a beta-blocker was \>65 beats per min, we sought to lower the heart rate by giving atenolol (25--75 mg) 1 h before scanning. Using an autoimpregnator, we injected 60--70 mL nonionic contrast medium (Ultravist 370, Schering, Germany) followed by saline (40 mL) into the ulnar artery. We electrocardiographically synchronized the heart CT and calculated each CACS via reconstruction (Wizard; Siemens, Erlangen, Germany). CACS was calculated using the method of Agatston. The coronary artery was divided into four segments, and the scores of each segment were calculated and summed. We used the extent of pigmentation to calculate each CACS (0, \>0).

### 2.2.4. Statistics {#sec2.2.4}

Data were compared using Statistical Package for the Social Sciences software, version 18.0 (SPSS Inc., Chicago, IL, USA). We compared between-group parameters using the *t*-test. To afford a 95% predictive power of an odds ratio (OR) of 2 at the 5% significance level, the two-tailed *t*-test indicated that 502 subjects were required \[[@B19]\]. ORs and 95% confidence intervals (CIs) were calculated by multivariate logistic regression. A *P* value \<0.05 was regarded as statistically significant.

### 2.2.5. Ethics Statement {#sec2.2.5}

This study was implemented in accordance with ethical and safety guidelines upon the approval of the Institutional Review Board in The Catholic University of Korea, St. Vincent\'s Hospital (IRB approval number: VC15RISI0068). The study was exempted from the written informed consent to participants because we reviewed the health screening data and medical record retrogradely. The IRBs approved this consent procedure.

3. Results {#sec3}
==========

3.1. General Subject Characteristics {#sec3.1}
------------------------------------

Of the 599 subjects, 473 (79%) had a CACS of 0 and 126 (21%) a CACS \> 0. The average age of the latter group was 56.06 ± 8.99 years, significantly higher than that of the CACS = 0 group (49.09 ± 56.06 years; *P* \< 0.001). In the CACS \> 0 group, WC, systolic blood pressure, and levels of ALT, GTP, TC, and TG were significantly higher than those of the CACS = 0 group. The WBC count and NLR did not differ significantly between the groups ([Table 1](#tab1){ref-type="table"}).

3.2. The Relationship between the CACS and CVD Risk Factors in All Subjects {#sec3.2}
---------------------------------------------------------------------------

Multivariate logistic regression was used to explore the relationships between the CACS and factors that might affect the CACS ([Table 2](#tab2){ref-type="table"}). Aging was an independent risk factor for an elevated CACS; as subject age increased, the CACS rose significantly (*P* \< 0.001). Males had higher CACSs than those of females, and, as the TG level increased, the CACS increased significantly (*P* = 0.019) ([Table 2](#tab2){ref-type="table"})

3.3. The Relationship between the CACS and CVD Risk Factors in Males {#sec3.3}
--------------------------------------------------------------------

We used multivariate logistic regression to evaluate 397 males in terms of the relationships between the CACS and factors that might affect the CACS. The CACS increased significantly (*P* \< 0.001) with the age of healthy asymptomatic males and was also significantly associated with elevated systolic blood pressure (*P* = 0.039). Of the hematological factors evaluated, the NLR was found to be an independent risk factor for an elevated CACS; the CACS increased significantly with the NLR (*P* = 0.045). Of the lipid-related factors, the higher the TG level, the higher the CACS (*P* = 0.022) ([Table 3](#tab3){ref-type="table"}). After adjusting other factors, area under the ROC curve of NLR in predicting CAC was 0.74 (95% CI = 0.66--0.82) ([Figure 1](#fig1){ref-type="fig"}).

3.4. The Relationship between the CACS and CVD Factors in Females {#sec3.4}
-----------------------------------------------------------------

Of all 136 women, age (*P* \< 0.001), body mass index (*P* = 0.011), and current smoking status (*P* = 0.002) independently and significantly affected the CACS. No significant relationship was evident between the NLR and CACS in females ([Table 4](#tab4){ref-type="table"}).

4. Discussion {#sec4}
=============

We explored the relationship between the NLR and the CACS to determine if the NLR (a measure of subclinical inflammation) predicted the extent of coronary artery calcification in asymptomatic subjects. For healthy males (but not females), an increase in the NLR was correlated independently with an increase in the CACS.

Inflammation plays critical roles in many coronary artery diseases \[[@B20]\]. Atherosclerosis is a complex of inflammatory diseases \[[@B21]\]. Leukocytes contribute substantially to progression of inflammation \[[@B22]\], and several prospective studies have found positive correlations between leukocyte (total and differential) counts and the development of CVD in both adult males and females \[[@B23], [@B24]\]. The NLR is a well-recognized biomarker of inflammation \[[@B25]\]. When the WBC count is within the normal range, a higher NLR is indicative of a greater risk of atherosclerotic disease \[[@B6]\]. The NLR is associated with other clinical inflammatory markers. Balta et al. reported that there were moderate positive correlations between carotid intima media thickness value, C-reactive protein, and NLR in patients with Behçet disease \[[@B26]\]. Unlike many other inflammatory markers, the NLR is inexpensive and readily available and it provides additional risk stratification beyond conventional risk scores \[[@B27]\]. However, NLR values may be changed by medications. Fici et al. reported that nebivolol improved NLR to a greater extent than metoprolol in patients with hypertension \[[@B28]\].

Balta et al. found that increased NLR may play a role not only in the pathogenesis of coronary artery disease but also in the pathophysiology of coronary artery ectasia \[[@B29]\]. Additionally, the NLR is associated with both the risk and severity of CVD \[[@B30]\]. Shen et al. found that the NLR significantly predicted long-term mortality in 551 STEMI patients who underwent early cardiac revascularization (hazard ratio 2.27, 95% CI 1.32--4.29; *P* = 0.002) \[[@B31]\]. Wang et al. performed a meta-analysis of 10 cohort studies on patients who underwent angiography or cardiac revascularization; the relative risk (RR) of all-cause mortality in the high-NLR group was 2.33 (95% CI 1.88--2.88), and the RR of a cardiovascular event was 1.89 (95% CI 1.88--2.88). Thus the NLR significantly predicted both all-cause mortality and cardiovascular events in patients with CVD \[[@B32]\].

Coronary artery calcification is closely associated with coronary artery disease \[[@B33]\]. The CACS reflects both the extent and distribution of coronary artery calcification, which reliably predicts the CVD risk \[[@B34]--[@B36]\]. As calcium deposits increase, so does the CVD risk \[[@B37]\]. One systematic study found that when the CACS was 0, the prevalence of CVD was 0.56%, and the negative predictive value 99% (thus very high) \[[@B38]\]. When the CACS was \<100, the risk of an angiographic diagnosis of significant coronary artery stenosis (\>50%) was \<3% \[[@B39]\]. In a 3-year study on 2,000 asymptomatic adults, a CAC \> 0 increased the risk of CVD 10.5-fold in males and 2.6-fold in females \[[@B40]\].

Turkmen et al. evaluated 56 patients (34 males, 22 females) with end-stage renal disease who were on dialysis for \>6 months. Except for in those with acute infections, autoimmune diseases, acute heart failure, or CVD, the NLR and CACS were significantly correlated (*r* = 0.3, *P* = 0.02) \[[@B41]\]. Also, in a study of 290 patients with type 2 diabetes mellitus, those with NLRs ≤2.05 had lower CACSs and a lower incidence of obstructive coronary artery disease than did those with NLRs \>2.05 \[[@B42]\]. Park et al. used multivariate logistic regression to show that a high NLR was independently associated with an elevated CACS in 849 Koreans \[[@B43]\]. The cited work included patients with hypertension and diabetes, and the data were not analyzed by sex. We excluded patients with diabetes or hypertension and showed that the NLR was correlated independently with the CACS (after adjustment for other CVD risk factors) of healthy adult males with FBG levels \<126 mg/dL, systolic blood pressure \<140 mmHg, and diastolic blood pressure \<90 mm Hg. Therefore, the NLR can be used to predict CVD not only in patients at high risk of CVD (such as those with diabetes, hypertension, and chronic renal failure) but also in asymptomatic healthy adult males.

We found that the TG level was independently associated with the CACS, in agreement with the data of Cao et al. \[[@B44]\]. Tirosh et al. evaluated 13,953 healthy adult males aged 26--45 years for 5 years and found a strong correlation between the TG level and the development of CVD \[[@B45]\]. A meta-analysis of studies on adults of mean age of 56.6 years, over a 12-year follow-up, found that the CVD risk was 1.8-fold greater in those with the highest 20% of TG levels, compared with those with the lowest 20% \[[@B47]\]. Also, in the Framingham study, the risk of CVD was 2-fold higher in those with TG levels of 250--400 mg/dL than in those with TG levels of 50--100 mg/dL \[[@B48]\]. The Copenhagen study recruited middle-aged males (\>54 years of age). In those with TG levels \>142 mg/dL, the adjusted RR of CVD was 2.2, significantly higher than the RRs of those with lower TG levels \[[@B49]\]. Tirosh et al. showed that elevated TG levels correlated significantly with the body mass index, the extent of physical activity, and breakfast habits \[[@B45]\]. Therefore, lifestyle-mediated management of TG levels will greatly lower the CVD risk.

We found a close association between female smoking and the CACS. Lehmann et al. reported that current smoking was an independent risk factor for a CACS \> 0, and that the time until reaching a CACS \> 0 was approximately 10 years less in current versus former smokers \[[@B50]\]. Smoking lowers the availability of nitrogen oxide, triggering endothelial and vasomotor dysfunction, activating leukocyte-endothelial cell interactions, triggering leucocyte recruitment, increasing the levels of proatherogenic substances by elevating proinflammatory cytokine levels, and triggering oxidative lipid modifications, culminating in atherosclerosis \[[@B51]\].

Our study had a few limitations. First, we considered only present smoking status; we did not record pack-years, and we did not consider alcohol ingestion, self-reporting bias, or stress associated with smoking. Thus, we found no relationship between smoking and the CACS in males. Had we considered the above factors, such an association might have become apparent. Second, our work was cross-sectional in nature; caution is thus appropriate when seeking to identify causative relationships.

In conclusion, we found an independent correlation between the NLR and the CACS in asymptomatic Korean adult males. The NLR can be used to predict CVD in subjects with subclinical atherosclerosis.
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###### 

Baseline characteristics of study populations.

                                CACS = 0         CACS \> 0        *P* value
  ----------------------------- ---------------- ---------------- -----------
  Age (year)                    49.04 ± 8.46     56.06 ± 9.00     \<0.001
  Sex                                                             \<0.001
   Male                         295 (74.3%)      102 (25.8%)       
   Female                       178 (88.1%)      24 (11.9%)        
  Smoking                                                         0.912
   Nonsmoker                    337 (78.7%)      91 (21.3%)        
   Smoker                       136 (79.5%)      35 (20.5%)        
  BMI (kg/m^2^)                 23.91 ± 2.70     24.62 ± 3.20     0.011
  WC (cm)                       84.31 ± 8.41     86.88 ± 8.42     0.003
  SBP (mmHg)                    119.43 ± 11.37   122.27 ± 10.10   0.007
  DBP (mmHg)                    72.68 ± 8.32     72.92 ± 7.54     0.761
  WBC (10^3^/*μ*L)              5.95 ± 1.58      6.24 ± 1.73      0.086
  Neutrophils (10^3^/*μ*L)      53.07 ± 8.78     52.19 ± 8.16     0.315
  Lymphocytes (10^3^/*μ*L)      36.28 ± 7.70     36.90 ± 7.88     0.435
  Neutrophil-lymphocyte ratio   1.59 ± 0.63      1.53 ± 0.60      0.416
  Hb                            14.78 ± 1.55     15.05 ± 1.37     0.059
  Albumin                       4.54 ± 0.29      4.47 ± 0.39      0.084
  FBS (mg/dL)                   92.03 ± 9.19     95.83 ± 10.77    \<0.001
  TG (mg/dL)                    124.83 ± 72.68   141.77 ± 72.70   0.020
  TC (mg/dL)                    201.98 ± 35.47   213.47 ± 64.24   0.008
  HDL-C (mg/dL)                 47.24 ± 11.00    45.40 ± 9.85     0.090
  AST (IU/L)                    22.06 ± 12.32    24.29 ± 11.54    0.068
  ALT (IU/L)                    25.49 ± 20.48    30.09 ± 24.59    0.032
  rGTP (IU/L)                   32.78 ± 33.16    44.85 ± 52.53    0.015
  Cr (mg/dL)                    0.84 ± 0.16      0.97 ± 0.74      0.061
  UA (mg/dL)                    5.58 ± 1.45      5.78 ± 1.37      0.182
  Ca                            9.09 ± 0.35      9.96 ± 8.99      0.317
  P                             3.27 ± 0.47      3.28 ± 0.46      0.735
  Ca/P Ratio                    2.84 ± 0.42      3.13 ± 3.27      0.360
  hsCRP (mg/dL)                 0.15 ± 0.35      0.20 ± 0.29      0.195

###### 

Odds ratios and 95% intervals for CACS in men and women in multivariate analysis.

  Variables                     OR      95% CI   *P* value   
  ----------------------------- ------- -------- ----------- ---------
  Age (year)                    1.166   1.101    1.234       \<0.001
  Female                        0.048   0.010    0.226       \<0.001
  Current smoker                0.601   0.221    1.633       0.318
  BMI (kg/m^2^)                 1.207   0.946    1.539       0.130
  WC (cm)                       0.934   0.854    1.022       0.136
  SBP (mmHg)                    1.041   0.987    1.098       0.135
  DBP (mmHg)                    0.961   0.895    1.032       0.271
  WBC (10^3^/*μ*L)              0.960   0.710    1.299       0.793
  Neutrophils (10^3^/*μ*L)      1.062   0.936    1.205       0.353
  Lymphocytes (10^3^/*μ*L)      1.101   0.938    1.279       0.208
  Neutrophil-lymphocyte ratio   2.209   0.222    21.938      0.499
  Hemoglobin                    0.652   0.439    0.967       0.034
  Albumin                       0.176   0.031    0.995       0.049
  FBS (mg/dL)                   0.993   0.951    1.037       0.760
  TC (mg/dL)                    0.999   0.990    1.009       0.854
  HDL-C (mg/dL)                 1.001   0.959    1.044       0.975
  TG (mg/dL)                    1.008   1.001    1.014       0.019
  AST (IU/L)                    1.076   1.008    1.147       0.027
  ALT (IU/L)                    0.997   0.960    1.035       0.870
  rGTP (IU/L)                   0.994   0.981    1.008       0.415
  Cr (mg/dL)                    2.261   0.422    12.119      0.341
  UA (mg/dL)                    1.077   0.794    1.461       0.635
  Ca                            1.912   0.362    3.388       0.315
  P                             0.642   0.008    5.640       0.843
  Ca/P ratio                    0.759   0.006    9.762       0.910
  hsCRP (mg/dL)                 1.078   0.340    3.411       0.899

###### 

Odds ratios and 95% intervals for CACS in men in multivariate analysis.

  Variables                     OR       95% CI   *P* value   
  ----------------------------- -------- -------- ----------- ---------
  Age (year)                    1.154    1.077    1.237       \<0.001
  Current smoker                0.499    0.159    1.565       0.233
  BMI (kg/m^2^)                 1.024    0.735    1.428       0.887
  WC (cm)                       0.946    0.839    1.066       0.362
  SBP (mmHg)                    1.076    1.004    1.153       0.039
  DBP (mmHg)                    0.924    0.846    1.010       0.083
  WBC (10^3^/*μ*L)              0.874    0.600    1.275       0.485
  Neutrophils (10^3^/*μ*L)      0.956    0.845    1.083       0.479
  Lymphocytes (10^3^/*μ*L)      1.148    0.966    1.365       0.118
  Neutrophil-lymphocyte ratio   7.464    1.047    53.212      0.045
  Hemoglobin                    0.584    0.343    0.993       0.047
  Albumin                       0.368    0.052    2.602       0.317
  FBS (mg/dL)                   0.970    0.921    1.022       0.257
  TC (mg/dL)                    1.004    0.994    1.014       0.445
  HDL-C (mg/dL)                 0.976    0.922    1.020       0.416
  TG (mg/dL)                    1.011    1.001    1.020       0.022
  AST (IU/L)                    1.095    1.007    1.189       0.033
  ALT (IU/L)                    0.984    0.940    1.030       0.487
  rGTP (IU/L)                   0.991    0.974    1.007       0.256
  Cr (mg/dL)                    2.240    0.506    9.918       0.288
  UA (mg/dL)                    0.988    0.693    1.409       0.948
  Ca                            3.376    0.241    47.210      0.366
  P                             10.477   0.028    39.128      0.437
  Ca/P ratio                    8.464    0.241    47.210      0.507
  hsCRP (mg/dL)                 3.251    0.385    27.422      0.279

###### 

Odds ratios and 95% intervals for CACS in women in multivariate analysis.

  Variables                     OR       95% CI   *P* value   
  ----------------------------- -------- -------- ----------- ---------
  Age (year)                    1.303    1.138    1.492       \<0.001
  Current smoker                99.872   5.450    1830.127    0.002
  BMI (kg/m^2^)                 1.735    1.135    2.654       0.011
  WC (cm)                       0.907    0.822    1.001       0.052
  SBP (mmHg)                    1.008    0.922    1.101       0.867
  DBP (mmHg)                    0.943    0.823    1.080       0.394
  Neutrophils (10^3^/*μ*L)      1.204    0.954    1.519       0.117
  Lymphocytes (10^3^/*μ*L)      0.798    0.596    1.067       0.128
  Neutrophil-lymphocyte ratio   0.010    0.000    2.585       0.104
  Hemoglobin                    0.748    0.391    1.432       0.381
  FBS (mg/dL)                   1.052    0.972    1.139       0.211
  TC (mg/dL)                    1.012    0.989    1.036       0.314
  HDL-C (mg/dL)                 0.977    0.905    1.055       0.553
  TG (mg/dL)                    0.989    0.977    1.002       0.095
  AST (IU/L)                    0.253    0.728    1.087       0.253
  ALT (IU/L)                    1.155    0.988    1.350       0.071
  rGTP (IU/L)                   0.975    0.926    1.027       0.348
  UA (mg/dL)                    0.567    0.239    1.344       0.198
  Ca                            6.326    0.291    12.826      0.167
  P                             0.163    0.000    13.897      0.694
  Ca/P ratio                    0.216    0.000    17.147      0.791
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